Dhampur Sugar can test Rs 140-145: Deshmukh

Published on Tue, Nov 10, 2009 at 14:46 |  Source : CNBC-TV18

Updated at Tue, Nov 10, 2009 at 18:22  

8471 Investors following Dhampur Sugar. Share this News with them.
0
0
Share on Tumblr
Akshata Deshmukh, Sr Research Analyst, Networth Stock Broking

Excerpts from Markets Midday on CNBC-TV18 Watch the full show ยป

ALSO READ

Dhampur Sugar Mills can test Rs 140-145, says Akshata Deshmukh , Sr Research Analyst, Networth Stock Broking.

Deshmukh told CNBC-TV18, "The entire sugar pack is seeing some resurgence off late and stocks like Shree Renuka Sugars today have tried breaking some short-term charts on the upside. However, I think Dhampur Sugar is one of the strongest charts amongst the entire pack and looking at the kind of volume expansion ever since the month of October where it has formed a base of Rs 94 levels, the immediate support I see on this chart is Rs 112 to Rs 114 levels where accumulation is recommended and the stock might test levels of Rs 140-145 in a couple of month's timeframe. I think the volumes are good and the long-term charts are definitely strong because the ascending scallop's pattern is still maintained on the charts. So I would prefer this stock to the others amongst the entire pack."

Disclosure: I do not have a personal holding in the above stock/sector but may have recommended them to clients.

  

More on Moneycontrol

Trending News

Business News

Apple rushing to finalize apps for iPad 3 announcement
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com